Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Heeney

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
EMBO Reports|October 11, 2023
Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus releaseHazel Stewart, Roberta Palmulli, Kristoffer H Johansen, et al.
Journal of Virology|March 16, 2004
Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infectionPetra Mooij, Ivonne G Nieuwenhuis, Christiaan J Knoop, et al.
Journal of Virology|March 27, 2009
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogensPetra Mooij, Sunita S Balla-Jhagjhoorsingh, Niels Beenhakker, et al.
Journal of Virology|July 1, 2006
Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzeesJonathan L Heeney, Erik Rutjens, Ernst J Verschoor, et al.
The Journal of Infection|May 19, 2026
A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus VaccineAlasdair Ps Munro, Matteo Ferrari, Rebecca Kinsley, et al.
Journal of Virology|May 8, 2021
SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing ResponsesGeorge W Carnell, Katarzyna A Ciazynska, David A Wells, et al.
Emerging Microbes & Infections|May 6, 2025
Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBDJoey Olivier, Charlotte George, Chloe Qingzhou Huang, et al.
Science Advances|January 7, 2022
SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egressKatharina M Scherer, Luca Mascheroni, George W Carnell, et al.
The Journal of Biological Chemistry|August 28, 2014
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1Rachel P J Lai, Miriam Hock, Jens Radzimanowski, et al.
Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures)|November 1, 2021
Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19Helen E Baxendale, David Wells, Jessica Gronlund, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
EMBO Reports|October 11, 2023
Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus releaseHazel Stewart, Roberta Palmulli, Kristoffer H Johansen, et al.
Journal of Virology|March 16, 2004
Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infectionPetra Mooij, Ivonne G Nieuwenhuis, Christiaan J Knoop, et al.
Journal of Virology|March 27, 2009
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogensPetra Mooij, Sunita S Balla-Jhagjhoorsingh, Niels Beenhakker, et al.
Journal of Virology|July 1, 2006
Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzeesJonathan L Heeney, Erik Rutjens, Ernst J Verschoor, et al.
The Journal of Infection|May 19, 2026
A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus VaccineAlasdair Ps Munro, Matteo Ferrari, Rebecca Kinsley, et al.
Journal of Virology|May 8, 2021
SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing ResponsesGeorge W Carnell, Katarzyna A Ciazynska, David A Wells, et al.
Emerging Microbes & Infections|May 6, 2025
Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBDJoey Olivier, Charlotte George, Chloe Qingzhou Huang, et al.
Science Advances|January 7, 2022
SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egressKatharina M Scherer, Luca Mascheroni, George W Carnell, et al.
The Journal of Biological Chemistry|August 28, 2014
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1Rachel P J Lai, Miriam Hock, Jens Radzimanowski, et al.
Journal of Critical Care Medicine (Universitatea De Medicina Si Farmacie Din Targu-Mures)|November 1, 2021
Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19Helen E Baxendale, David Wells, Jessica Gronlund, et al.
Pageof 12